AbsEn.i
Analysis
2020
Racine
Analysis
2020
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Analysis (2020)

Index « AbsEn.i » - entrée « course »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
coupled < course < courses  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 19.
Ident.Authors (with country if any)Title
000005 (2020) Tadeusz Płusa[Options for controlling new Corona virus infection - 2019-nCoV].
000006 (2020) Anna Jakubczyc ; Claus Neurohr[Interstitial lung disease in rheumatic diseases - new therapeutic approaches].
000110 (2020) Anna Gluba-Brz Zka ; Beata Franczyk ; Robert Olszewski ; Jacek RyszThe Influence of Inflammation on Anemia in CKD Patients
000167 (2020) Peter A. Riedell ; Michael R. BishopSafety and efficacy of axicabtagene ciloleucel in refractory large B-cell lymphomas
000218 (2020) Piero Ruscitti [Italie] ; Paola Cipriani [Italie] ; Vasiliki Liakouli [Italie] ; Daniela Iacono [Italie] ; Ilenia Pantano [Italie] ; Francesco Caso [Italie] ; Federico Perosa [Italie] ; Fabiola Atzeni [Italie] ; Francesco Paolo Cantatore [Italie] ; Raffaele Scarpa [Italie] ; Francesco Ciccia [Italie] ; Roberto Giacomelli [Italie]Prescribing motivations and patients' characteristics related to the use of biologic drugs in adult-onset Still's disease: analysis of a multicentre "real-life" cohort.
000255 (2020) Domenico Umberto De Rose [Italie] ; Fiammetta Piersigilli [Italie, Belgique] ; Maria Paola Ronchetti [Italie] ; Alessandra Santisi [Italie] ; Iliana Bersani [Italie] ; Andrea Dotta [Italie] ; Olivier Danhaive [Belgique] ; Cinzia Auriti [Italie]Novel Coronavirus disease (COVID-19) in newborns and infants: what we know so far
000293 (2020) Hermine I. Brunner [États-Unis] ; Nikolay Tzaribachev [Allemagne] ; Gabriel Vega Cornejo ; Rik Joos [Belgique] ; Elisabeth Gervais [France] ; Rolando Cimaz [Italie] ; Inmaculada Calvo Penadés [Espagne] ; Rubén Cuttica [Argentine] ; Thomas Lutz [Allemagne] ; Pierre Quartier [France] ; Yash Gandhi [États-Unis] ; Marleen Nys [Belgique] ; Robert Wong [États-Unis] ; Alberto Martini [Italie] ; Daniel J. Lovell [États-Unis] ; Nicolino Ruperto [Italie]Maintenance of antibody response to diphtheria/tetanus vaccine in patients aged 2–5 years with polyarticular-course juvenile idiopathic arthritis receiving subcutaneous abatacept
000296 (2020) Mayan Gilboa [Israël] ; Gil Bornstein [Israël] ; Ilan Ben-Zvi [Israël] ; Chagai Grossman [Israël]Macrophage activation syndrome complicating rheumatic diseases in adults: case-based review.
000361 (2020) Kunihiko Umekita ; Akihiko OkayamaHTLV-1 Infection and Rheumatic Diseases
000393 (2020) Dinesh Khanna ; Donald P. Tashkin ; Christopher P. Denton ; Elisabetta A. Renzoni ; Sujal R. Desai ; John VargaEtiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease
000403 (2020) Hiroki Hoshino [Japon] ; Yoko Shirai [Japon] ; Hiroe Konishi [Japon] ; Takashi Yamamura [Japon] ; Norikazu Shimizu [Japon]Efficacy of tocilizumab for fulminant multiple sclerosis with a tumefactive cervical lesion: A 12-year-old boy.
000453 (2020) Cristina Scavone [Italie] ; Simona Brusco [Italie] ; Michele Bertini [Italie] ; Liberata Sportiello [Italie] ; Concetta Rafaniello [Italie] ; Alice Zoccoli [Italie] ; Liberato Berrino [Italie] ; Giorgio Racagni [Italie] ; Francesco Rossi [Italie] ; Annalisa Capuano [Italie]Current pharmacological treatments for COVID-19: what's next?
000454 (2020) He Huang [République populaire de Chine] ; Heng-Wei Wu [République populaire de Chine] ; Yong-Xian Hu [République populaire de Chine]Current advances in chimeric antigen receptor T-cell therapy for refractory/relapsed multiple myeloma
000514 (2020) Fatih Ha Lak [Turquie] ; Mehmet Y Ld Z [Turquie] ; Amra Adrovic [Turquie] ; Kenan Barut [Turquie] ; Özgür Kasapçopur [Turquie]Childhood Rheumatic Diseases and COVID-19 Pandemic: An Intriguing Linkage and a New Horizon
000552 (2020) Tomasz J. Guzik [Royaume-Uni] ; Saidi A. Mohiddin [Royaume-Uni] ; Anthony Dimarco [Royaume-Uni] ; Vimal Patel [Royaume-Uni] ; Kostas Savvatis [Royaume-Uni] ; Federica M. Marelli-Berg [Royaume-Uni] ; Meena S. Madhur [États-Unis] ; Maciej Tomaszewski [Royaume-Uni] ; Pasquale Maffia [Royaume-Uni] ; Fulvio D'Acquisto [Royaume-Uni] ; Stuart A. Nicklin [Royaume-Uni] ; Ali J. Marian [États-Unis] ; Ryszard Nosalski [Royaume-Uni] ; Eleanor C. Murray [Royaume-Uni] ; Bartlomiej Guzik [Pologne] ; Colin Berry [Royaume-Uni] ; Rhian M. Touyz [Royaume-Uni] ; Reinhold Kreutz [Allemagne] ; Dao Wen Wang [République populaire de Chine] ; David Bhella [Royaume-Uni] ; Orlando Sagliocco [Italie] ; Filippo Crea [Italie] ; Emma C. Thomson [Royaume-Uni] ; Iain B. Mcinnes [Royaume-Uni]COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options.
000554 (2020) Sevim Zaim [Royaume-Uni] ; Jun Heng Chong [Royaume-Uni] ; Vissagan Sankaranarayanan [Royaume-Uni] ; Amer Harky [Royaume-Uni]COVID-19 and Multi-Organ Response
000565 (2020) Ali Aminian [États-Unis] ; Mohammad Kermansaravi [Iran] ; Shahriar Azizi [Iran] ; Peyman Alibeigi [Iran] ; Sina Safamanesh [Iran] ; Ali Mousavimaleki [Iran] ; Mohammad Taghi Rezaei [Iran] ; Maziar Faridi [Iran] ; Somayeh Mokhber [Iran] ; Abdolreza Pazouki [Iran] ; Saeed Safari [Iran]Bariatric Surgical Practice During the Initial Phase of COVID-19 Outbreak
000590 (2020) Lingshu Zhang [États-Unis, République populaire de Chine] ; Pingfang Song [États-Unis] ; Xiaowei Zhang [États-Unis] ; Christina Metea [États-Unis] ; Matthew Schleisman [États-Unis] ; Lisa Karstens [États-Unis] ; Eric Leung [États-Unis] ; Jun Zhang [États-Unis] ; Qiang Xu [États-Unis, République populaire de Chine] ; Yi Liu [République populaire de Chine] ; Mark Asquith [États-Unis] ; Cong-Qiu Chu [États-Unis]Alpha-Glucosidase Inhibitors Alter Gut Microbiota and Ameliorate Collagen-Induced Arthritis
000624 (2015) Raja Atreya [Allemagne] ; Ulrike Billmeier [Allemagne] ; Timo Rath [Allemagne] ; Jonas Mudter [Allemagne] ; Michael Vieth [Allemagne] ; Helmut Neumann [Allemagne] ; Markus F. Neurath [Allemagne]First case report of exacerbated ulcerative colitis after anti-interleukin-6R salvage therapy.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i -k "course" 

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i  \
                -Sk "course" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    course
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021